Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Net income as a percentage of revenue
Latest
-5.63%
↑ 95% vs avg
Percentile
P88
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
-121.35%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -5.63% | +63.9% |
| 2024 | -15.57% | +91.3% |
| 2023 | -179.87% | +41.9% |
| 2022 | -309.58% | +9.8% |
| 2021 | -343.04% | -443.8% |
| 2020 | -63.09% | +3.7% |
| 2019 | -65.49% | +40.1% |
| 2018 | -109.40% | -20770.5% |
| 2013 | -0.52% | - |